NCT07614022
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07614022
Title A Phase I Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive ALL
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Wake Forest University Health Sciences
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Atrium Health Levine Cancer Charlotte North Carolina 28204 United States Details
Atrium Health Wake Forest Baptist Comprehensive Cancer Center Winston-Salem North Carolina 27157 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field